Assessing MicroStrategy (MSTR) Valuation After A Steep Pullback And Depressed Price To Book Ratio

Simply Wall St

Event context and recent performance

Strategy (MSTR) has drawn attention after a period of share price weakness, with the stock down 8% over the past day, 14% over the past week, and 38% over the past month.

See our latest analysis for Strategy.

The recent slide adds to a weak year to date, with the share price return down 25.54%, while the 1 year total shareholder return has fallen 70.09% even after a very large 3 year total shareholder return of about 3x.

If this kind of volatility has you looking beyond a single bitcoin treasury stock, it could be a good moment to scan for other cryptocurrency focused opportunities using the 20 cryptocurrency and blockchain stocks.

With the share price under pressure, a value score of 4, an intrinsic discount of 25%, and a current price slightly below analyst targets, the key question is whether this is a genuine entry point or if markets already reflect future growth.

Preferred multiple of 1.1x P/B: Is it justified?

On a simple yardstick, Strategy looks inexpensive, with its 1.1x P/B ratio sitting well below both peer and broader software industry averages, while the share price has come under pressure.

P/B compares the market value of the equity to the accounting value of net assets. It can be a useful cross check for a company that holds a large financial asset such as bitcoin alongside an established software business.

Here, the discount is clear. Strategy is described as good value versus its peer group average P/B of 6.2x and the wider US Software industry average of 2.9x. This indicates that the market is pricing its balance sheet and future earnings potential at a considerable markdown.

Investors can also compare that picture with the SWS DCF model, which puts fair value at $156.11 per share versus the last close of $117.02, indicating potential upside based on projected future cash flows.

See what the numbers say about this price — find out in our valuation breakdown.

Result: Price-to-book of 1.1x (UNDERVALUED)

However, this potential upside sits alongside clear risks, including bitcoin price volatility and Strategy’s recent loss of US$12,773.698 in net income.

Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page.

Another view: DCF points to a different story

The low 1.1x P/B ratio suggests the stock is inexpensive, but the SWS DCF model provides a more detailed perspective. On that measure, fair value is $156.11 per share compared with the current $117.02 price. This difference indicates the market may be discounting future cash flows too heavily. The question is whether that gap reflects caution about bitcoin risk and profitability, or whether sentiment has swung too far.

Look into how the SWS DCF model arrives at its fair value.

MSTR Discounted Cash Flow as at Jun 2026

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Strategy for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 46 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

With sentiment clearly mixed, this is a moment to move quickly, look through the numbers yourself and test whether the current price matches your expectations. To see both the potential upside and the main concerns in one place, review the 2 key rewards and 1 important warning sign.

Looking for more investment ideas?

If you are weighing what to do next, do not stop at a single stock. Widen your view and line up a few fresh ideas to compare.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're here to simplify it.

Discover if Strategy might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com